View Item 

Show simple item record

SCAI guidelines on device selection in Aorto- Iliac arterial interventions
dc.contributor.authorFeldman, Dmitriy N.
dc.contributor.authorArmstrong, Ehrin J.
dc.contributor.authorAronow, Herbert D.
dc.contributor.authorBanerjee, Subhash
dc.contributor.authorDíaz‐sandoval, Larry J.
dc.contributor.authorJaff, Michael R.
dc.contributor.authorJayasuriya, Sasanka
dc.contributor.authorKhan, Safi U.
dc.contributor.authorKlein, Andrew J.
dc.contributor.authorParikh, Sahil A.
dc.contributor.authorRosenfield, Kenneth
dc.contributor.authorShishehbor, Mehdi H.
dc.contributor.authorSwaminathan, Rajesh V.
dc.contributor.authorWhite, Christopher J.
dc.date.accessioned2020-11-04T15:58:18Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-11-04T15:58:18Z
dc.date.issued2020-10-01
dc.identifier.citationFeldman, Dmitriy N.; Armstrong, Ehrin J.; Aronow, Herbert D.; Banerjee, Subhash; Díaz‐sandoval, Larry J. ; Jaff, Michael R.; Jayasuriya, Sasanka; Khan, Safi U.; Klein, Andrew J.; Parikh, Sahil A.; Rosenfield, Kenneth; Shishehbor, Mehdi H.; Swaminathan, Rajesh V.; White, Christopher J. (2020). "SCAI guidelines on device selection in Aorto- Iliac arterial interventions." Catheterization and Cardiovascular Interventions 96(4): 915-929.
dc.identifier.issn1522-1946
dc.identifier.issn1522-726X
dc.identifier.urihttps://hdl.handle.net/2027.42/163378
dc.publisherJohn Wiley & Sons, Inc.
dc.titleSCAI guidelines on device selection in Aorto- Iliac arterial interventions
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163378/2/ccd28947_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163378/1/ccd28947.pdfen_US
dc.identifier.doi10.1002/ccd.28947
dc.identifier.sourceCatheterization and Cardiovascular Interventions
dc.identifier.citedreferenceBismuth J, Gray BH, Holden A, Metzger C, Panneton J, VBX FLEX Study Investigators. Pivotal study of a next- generation balloon- expandable stent- graft for treatment of iliac occlusive disease. J Endovasc Ther. 2017; 24 ( 5 ): 629 - 637.
dc.identifier.citedreferenceDake MD, Ansel GM, Jaff MR, et al. Paclitaxel- eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve- month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011; 4: 495 - 504.
dc.identifier.citedreferenceBrodmann M, Holden A, Zeller T. Safety and feasibility of intravascular lithotripsy for treatment of below- the- knee arterial Stenoses. J Endovasc Ther. 2018; 25: 499 - 503.
dc.identifier.citedreferenceGray WA, Keirse K, Soga Y, et al. A polymer- coated, pacliaxtel- eluting stent (Eluvia) versus a polymer- free, paclitaxel- coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomized, non- inferiority trial. Lancet. 2018; 392: 1541 - 1551.
dc.identifier.citedreferenceElens M, Verhelst R, Possoz J, Mastrobuoni S, Lacroix V, Astarci P. Short- term results of eluvia paclitaxel- eluting stent in external iliac and femoropopliteal lesions. Surg Technol Int. 2017; 31: 162 - 167.
dc.identifier.citedreferenceKatsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel- coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta- analysis of randomized controlled trials. J Am Heart Assoc. 2018; 7: e011245.
dc.identifier.citedreferenceTreatment of peripheral arterial disease with Paclitaxel- coated balloons and paclitaxel- eluting stents potentially associated with increased mortality - letter to health care providers [Internet]. U.S. Food and Drug Administration; August 2019 [cited August 27, 2019]. https://www.fda.gov/medical-devices/letters-health-care-providers/august-7-2019-update-treatment-peripheral-arterial-disease-paclitaxel-coated-balloons-and-paclitaxel.
dc.identifier.citedreferenceMwipatayi BP, Thomas S, Wong J, et al. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2011; 54 ( 6 ): 1561 - 1570.
dc.identifier.citedreferenceMwipatayi BP, Sharma S, Daneshmand A, et al. Durability of the balloon- expandable covered versus bare- metal stents in the covered versus balloon expandable stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2016; 64 ( 1 ): 83 - 94.e1.
dc.identifier.citedreferenceHumphries MD, Armstrong E, Laird J, Paz J, Pevec W. Outcomes of covered versus bare- metal balloon- expandable stents for aortoiliac occlusive disease. J Vasc Surg. 2014; 60 ( 2 ): 337 - 343.
dc.identifier.citedreferenceTaeymans K, Groot Jebbink E, Holewijn S, et al. Three- year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J Vasc Surg. 2018; 67 ( 5 ): 1438 - 1447.
dc.identifier.citedreferenceHolden A, Merrilees S, Buckley B, Connor B, Colgan F, Hill A. First- in- human experience with the Gore balloon- expandable covered Endoprosthesis in iliac artery occlusive disease. J Endovasc Ther. 2017; 24 ( 1 ): 11 - 18.
dc.identifier.citedreferenceLammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self- expanding stent- graft. Int Trial Study Group Radiol. 2000; 217 ( 1 ): 95 - 104.
dc.identifier.citedreferencePiazza M, Squizzato F, Dall’Antonia A, et al. Editor’s choice - outcomes of self expanding PTFE covered stent versus bare metal stent for chronic iliac artery occlusion in matched cohorts using propensity score modelling. Eur J Vasc Endovasc Surg. 2017; 54 ( 2 ): 177 - 185.
dc.identifier.citedreferenceLaird JR, Zeller T, Holden A, et al. Balloon- expandable vascular covered stent in the treatment of iliac artery occlusive disease: 9- month results from the BOLSTER multicenter study. J Vasc Interv Radiol. 2019; 30 ( 6 ): 836 - 844.e1.
dc.identifier.citedreferenceHajibandeh S, Hajibandeh S, Antoniou SA, Torella F, Antoniou GA. Covered vs uncovered stents for aortoiliac and femoropopliteal arterial disease: a systematic review and meta- analysis. J Endovasc Ther. 2016; 23 ( 3 ): 442 - 452.
dc.identifier.citedreferenceLee MS, Martinsen BJ. Acute procedural outcomes of orbital atherectomy for the treatment of iliac artery disease: sub- analysis of the CONFIRM registries. Cardiovasc Revasc med. 2018; 19: 503 - 505.
dc.identifier.citedreferenceFava M, Loyola S, Polydorou A, et al. Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol. 2004; 15: 1239 - 1243.
dc.identifier.citedreferenceLaird J, Jaff MR, Biamino G, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol. 2005; 16: 1067 - 1073.
dc.identifier.citedreferenceLaird JR, Biamino G, McNamara T, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow- up results. J Endovasc Ther. 2006; 13 ( Suppl 2 ): II52 - II59.
dc.identifier.citedreferenceMcCaslin JE, Andras A, Stansby G. Cryoplasty for peripheral arterial disease. Cochrane Database Syst Rev. 2013; 8: CD005507.
dc.identifier.citedreferenceAksoy A, Salazar C, Becher MU, et al. Intravascular lithotripsy in calcified coronary lesions: a prospective, observational, multicenter registry. Circ Cardiovasc Interv. 2019; 12: e008154.
dc.identifier.citedreferenceBrinton TJ, Ali ZA, Hill JM, et al. Feasibility of shockwave coronary intravascular lithotripsy for the treatment of calcified coronary stenoses. Circulation. 2019; 139: 834 - 836.
dc.identifier.citedreferenceAli ZA, Nef H, Escaned J, et al. Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the disrupt CAD II study. Circ Cardiovasc Interv. 2019; 12: e008434.
dc.identifier.citedreferenceBrodmann M, Werner M, Holden A, et al. Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: results of disrupt PAD II. Catheter Cardiovasc Interv. 2019; 93: 335 - 342.
dc.identifier.citedreferenceRadaideh Q, Shammas NW, Shammas GA, Shammas J. Safety and efficacy of lithoplasty in treating severely calcified iliac arterial disease: a single center experience. Vasc. Dis. Manag. 2019; 16: E76 - E78.
dc.identifier.citedreferenceRistalli F, Dini CS, Stolcova M, et al. Role of lithotripsy for small calcified iliacs in the era of big devices. Curr Cardiol Rep. 2019; 21: 143.
dc.identifier.citedreferenceKlein AJ, Jaff MR, Gray BH, et al. SCAI appropriate use criteria for peripheral arterial interventions: an update. Catheter Cardiovasc Interv. 2017; 90: E90 - E110.
dc.identifier.citedreferenceBailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ. ACC/AHA/SCAI/SIR/SVM 2018 appropriate use criteria for peripheral artery intervention: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine. J Am Coll Cardiol. 2019; 73: 214 - 237.
dc.identifier.citedreferenceFeldman DN, Armstrong EJ, Aronow HD, et al. SCAI consensus guidelines for device selection in femoral- popliteal arterial interventions. Catheter Cardiovasc Interv. 2018; 92: 124 - 140.
dc.identifier.citedreferenceJaff MR, White CJ, Hiatt WR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below- the- knee arteries: a supplement to the inter- society consensus for the management of peripheral arterial disease (TASC II): the TASC steering committee. Catheter Cardiovasc Interv. 2015; 86: 611 - 625.
dc.identifier.citedreferencePatel MR, Conte MS, Cutlip DE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015; 65: 931 - 941.
dc.identifier.citedreferenceAboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle- brachial index: a scientific statement from the American Heart Association. Circulation. 2012; 126: 2890 - 2899.
dc.identifier.citedreferenceMohler ER III, Gornik HL, Gerhard- Herman M, Misra S, Olin JW, Zierler RE. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiologic testing part 1: arterial ultrasound and physiologic testing. J Am Coll Cardiol. 2012; 60: 242 - 276.
dc.identifier.citedreferenceMcDermott MM, Guralnik JM, Criqui MH, Liu K, Kibbe MR, Fernucci L. Six- minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation. 2014; 130: 61 - 68.
dc.identifier.citedreferenceGreenhalgh RM, Belch JJ, Brown LC, et al. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomized trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg. 2008; 36 ( 6 ): 680 - 688.
dc.identifier.citedreferenceJohnston KW, Rae M, Hogg- Johnston SA, et al. 5- year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg. 1987; 206 ( 4 ): 403 - 413.
dc.identifier.citedreferenceHassen- Khodja R, Sala F, Declemy Sl Bouillanne PJ, Batt M, Staccini P. Value of stent placement during percutaneous transluminal angioplasty of the iliac arteries. J Cardiovasc Surg (Torino). 2001; 42 ( 3 ): 369 - 374.
dc.identifier.citedreferenceBlankensteijn JD, van Vroonhoven TJ, Lampmann L. Role of percutaneous transluminal angioplasty in aorto- iliac reconstruction. J Cardiovasc Surg. 1986; 27: 466 - 468.
dc.identifier.citedreferenceColapinto RF, Stronell RD, Johnston WK. Transluminal angioplasty of complete iliac obstructions. AJR Am J Roentgenol. 1986; 146: 859 - 862.
dc.identifier.citedreferenceGoode SD, Cleveland TJ, Gaines PA, STAG Trial Collaborators. Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial). Br J Surg. 2013; 100: 1148 - 1153.
dc.identifier.citedreferenceTetteroo E, van der Graaf Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliacartery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351: 1153 - 1159.
dc.identifier.citedreferenceKlein WM, van der Graaf Y, Seegers J, et al. Dutch iliac stent trial. Long term results in patients randomized for primary or selective stent placement. Radiology. 2006; 238: 734 - 744.
dc.identifier.citedreferenceBekken J, Jongsma H, Ayez N, Hoogewerf CJ, Van Well V, Fioole B. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev. 2015; 5: CD007561.
dc.identifier.citedreferenceThomas MP, Park YJ, Grey S, et al. Temporal trends in peripheral arterial interventions: observations from the blue cross blue shield of Michigan cardiovascular consortium (BMC2 PVI). Catheter Cardiovasc Interv. 2017; 89 ( 4 ): 728 - 734.
dc.identifier.citedreferenceTsetis D, Belli AM, Morgan R, et al. Preliminary experience with cutting balloon angioplasty for iliac artery in- stent restenosis. J Endovasc Ther. 2008; 15: 193 - 202.
dc.identifier.citedreferenceBosch JL, Hunink MG. Meta- analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997; 204: 87 - 96.
dc.identifier.citedreferenceKlein AJ, Feldman DN, Aronow HD, et al. SCAI expert consensus statement for aorto- iliac arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014; 84: 520 - 528.
dc.identifier.citedreferenceDyet JF, Watts WG, Ettles DF, Nicholson AA. Mechanical properties of metallic stents: how do these properties influence the choice of stent for specific lesions? Cardiovasc Intervent Radiol. 2000; 23: 47 - 54.
dc.identifier.citedreferenceFeldman DN, Klein AJP. Stent selection in the iliac arteries: don’t fall through the ICE! JACC Cardiovasc Interv. 2017; 10: 1705 - 1707.
dc.identifier.citedreferenceAihara H, Soga Y, Iida O, et al. Long- term outcomes of endovascular therapy for aortoiliac bifurcation lesions in the real- AI registry. J Endovasc Ther. 2014; 21: 25 - 33.
dc.identifier.citedreferencede Donato G, Bosiers M, Setacci F, et al. 24- month data from the BRAVISSIMO: a large- scale prospective registry on iliac stenting for TASC A & B and TASC C & D Lesions. Ann Vasc Surg. 2015; 29: 738 - 750.
dc.identifier.citedreferenceKrankenberg H, Zeller T, Ingwersen M, et al. Self- expanding versus balloon- expandable stents for iliac artery occlusive disease the randomized ICE trial (iliac artery stents for common or external iliac artery occlusive disease). JACC Cardiovasc Interv. 2017; 10: 1694 - 1704.
dc.identifier.citedreferenceSoga Y, Iida O, Kawasaki D, et al. Contemporary outcomes after endovascular treatment for aorto- iliac artery disease. Circ J. 2012; 76: 2697 - 2704.
dc.identifier.citedreferencePonec D, Jaff MR, Swischuk J, et al. The nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP- US trial results. J Vasc Interv Radiol. 2004; 15: 911 - 918.
dc.identifier.citedreferenceJaved U, Balwanz CR, Armstrong EJ, et al. Mid- term outcomes following endovascular re- intervention for iliac artery in- stent restenosis. Catheter Cardiovasc Interv. 2013; 82: 1176 - 1184.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ccd28947.pdf
Size:
5.031MB
Format:
PDF
View/Open
Name:
ccd28947_am.pdf
Size:
1.114MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.